Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study

Gynecologic Oncology Reports

Volumn 13, Issue , 2015, Pages 13-17

  Felix, Ashley S ^a   Bunch, Kristen ^b   Yang, Hannah P ^a   Arem, Hannah ^a   Trabert, Britton ^a   Gierach, Gretchen L ^a   Park, Yikyung ^a   Lowery, William J ^b   Brinton, Louise A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Estrogen plus progestin; Menopausal hormone therapy; Mortality; Ovarian cancer

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; COHORT ANALYSIS; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL HORMONE THERAPY; MENOPAUSE; MIDDLE AGED; OVARY CARCINOMA; SMOKING;

EID: 84964720211     PISSN: None     EISSN: 23525789     Source Type: Journal    
DOI: 10.1016/j.gore.2015.04.007     Document Type: Article

References (15)

1. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, and et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 3 2002 321 333
2. B. Ettinger, S.M. Wang, R.S. Leslie, B.V. Patel, M.J. Boulware, M.E. Mann, and et al. Evolution of postmenopausal hormone therapy between 2002 and 2009 Menopause 19 6 2012 610 615
3. H.P. Yang, W.F. Anderson, P.S. Rosenberg, B. Trabert, G.L. Gierach, N. Wentzensen, and et al. Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States J. Clin. Oncol. 31 17 2013 2146 2151
4. J. Hunn, and G.C. Rodriguez Ovarian cancer: etiology, risk factors, and epidemiology Clin. Obstet. Gynecol. 55 1 2012 3 23
5. B.R. Rao, and B.J. Slotman Endocrine factors in common epithelial ovarian cancer Endocr. Rev. 12 1 1991 14 26
6. Collaborative Group On Epidemiological Studies Of Ovarian Cancer Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies Lancet 2015 (Pubmed ID: 25684585)
7. A. Schatzkin, A.F. Subar, F.E. Thompson, L.C. Harlan, J. Tangrea, A.R. Hollenbeck, and et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study Am. J. Epidemiol. 154 12 2001 1119 1125
8. J.V. Lacey Jr., M.F. Leitzmann, S.C. Chang, T. Mouw, A.R. Hollenbeck, A. Schatzkin, and et al. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort Cancer 109 7 2007 1303 1311
9. C. Mascarenhas, M. Lambe, R. Bellocco, K. Bergfeldt, T. Riman, I. Persson, and et al. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival Int. J. Cancer 119 12 2006 2907 2915
10. K.J. Wernli, P.A. Newcomb, J.M. Hampton, A. Trentham-Dietz, and K.M. Egan Hormone therapy and ovarian cancer: incidence and survival Cancer Causes Control 19 6 2008 605 613
11. A. Hein, F.C. Thiel, C.M. Bayer, P.A. Fasching, L. Haberle, M.P. Lux, and et al. Hormone replacement therapy and prognosis in ovarian cancer patients Eur. J. Cancer Prev. 22 1 2013 52 58
12. C.C. Slater, C. Zhang, H.N. Hodis, W.J. Mack, R. Boostanfar, D. Shoupe, and et al. Comparison of estrogen and androgen levels after oral estrogen replacement therapy J. Reprod. Med. 46 12 2001 1052 1056
13. K.L. Edlefsen, R.D. Jackson, R.L. Prentice, I. Janssen, A. Rajkovic, M.J. O'Sullivan, and et al. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women Menopause 17 3 2010 622 629
14. M.A. Spillman, N.G. Manning, W.W. Dye, C.A. Sartorius, M.D. Post, J.C. Harrell, and et al. Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis Cancer Res. 70 21 2010 8927 8936
15. R. Fauvet, C. Dufournet Etienne, C. Poncelet, A.F. Bringuier, G. Feldmann, and E. Darai Effects of progesterone and anti-progestin (mifepristone) treatment on proliferation and apoptosis of the human ovarian cancer cell line, OVCAR-3 Oncol. Rep. 15 4 2006 743 748